Role of Lactoferrin tablets in post refractive surgery dry eye.

To study the impact of oral administration of lactoferrin in post refractive surgery dry eye. - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079391

Enrollment

128

Registered

2025-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: Lactoferrin: Lactoferrin is a globular glycoprotein used as a nutritional supplement. Lactoferrin tablets (100mg) will be given after refractive surgery for 2 times a day for 3 months.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing refractive surgery. 2.Willingness to sign written informed consent and follow up.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of ocular surgery other than refractive surgery. 2.Pregnancy and feeding mothers. 3.Lactose intolerance or cow milk allergy. 4.Patients not willing for participate and follow ups.

Design outcomes

Secondary

Measure	Time frame
Bioavailability of lactoferrin in tear filmTimepoint: Tear samples will be collected at baseline, before surgery then 1 month, 3 month and 6 month post refractive surgery	—

Primary

Measure	Time frame
Prevalence of post refractive surgery dry eye comes to 10% from 35% at 6 month post surgeryTimepoint: Prevalence of post refractive surgery dry eye comes to 10% from 35% at 6 month post surgery	—

Countries

India

Contacts

Public ContactDr Namrata Sharma

AIIMS

namrata.sharma@gmail.com9810856988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026